New treatment available for allergic rhinitis

Source-stated date: 25 October 2026 · PLA Daily (解放军报)

过敏性鼻炎有了新疗法

Machine translation The heading is a machine translation of the original title above. Human review is not recorded.

Record history

Published25 October 2026, by CMC Political Work Department
Collected2026-10-25 17:03:39 UTC, run 183
Machine readingNot selected for analysis
AnalysisNot in a published issue's source trail

Stored source text

Source record

Text captured from the source page. Extraction may omit material or include unrelated page elements; consult the original URL when exact wording or completeness matters.

过敏性鼻炎有了新疗法 ■卞卡赵丹入秋后，不少战友出现鼻塞、频繁打喷嚏、鼻痒等症状，还常常伴随眼痒、流泪、眼红等眼部过敏症状，影响日常训练。这很可能是过敏体质人群接触花粉、尘螨等过敏原后，引起的鼻黏膜慢性过敏性炎症。过敏性鼻炎的产生，是体内免疫系统错误地把无害物质当成“敌人”，释放大量炎症因子，进而引发鼻痒、打喷嚏、流清涕、鼻塞等症状。秋季之所以是过敏性鼻炎的高发期，与此时的花粉特点密切相关。秋季花粉大多来源于杂草，颗粒小且干燥，极易飘浮在空气中。例如，蒿草花粉就是重要的致敏原之一，很多战友只是少量接触就可能发生严重的过敏反应。面对过敏性鼻炎，传统的治疗方法主要包括以下3类：一是“避”，即脱离过敏原，如在花粉季佩戴口罩、勤除螨虫等。二是“控”，通过使用鼻用糖皮质激素、口服或鼻用抗组胺药来控制症状。三是“脱”，即过敏原特异性免疫治疗，俗称脱敏治疗，就是让身体反复、小剂量接触过敏原，逐渐变得不再那么敏感。脱敏治疗是目前唯一可能改变疾病进程的对因治疗方法，但缺点是起效慢，疗程通常需要持续3~5年，且并非人人适合。不少患者就医后问过同一个问题：口服药吃了，鼻喷剂也用了，为什么就是不见好？有没有“打一针就见效”的办法？对于一些中重度过敏性鼻炎患者来说，即便经过了规范的药物治疗，症状可能依然控制不佳、反复发作。除了上述传统方法外，还可以尝试一种新的治疗方法——生物制剂。生物制剂能够精确识别并中和过敏炎症通路中的关键信号分子，从炎症的源头阻断过敏反应。通俗地说，它就像一针“针对性很强的药”，直击过敏反应的关键环节。例如，司普奇拜单抗，是目前全球唯一获批用于治疗中重度季节性过敏性鼻炎的IL-4Rα抗体药物，同时也是国产首个用于治疗中重度特应性皮炎的生物制剂。生物制剂并非适合所有过敏性鼻炎患者，它有明确的临床适用范围。一般来说，18岁及以上成人患者可考虑使用生物制剂，治疗前提主要包括以下几项：经过规范的鼻用糖皮质激素联合口服或鼻用抗组胺药等标准治疗后，症状仍然控制不佳、反复发作的中重度患者，尤其是那些可能伴有2型炎症相关指标升高（如血嗜酸性粒细胞计数≥300个/μL等）的人群；合并有过敏性哮喘、慢性鼻窦炎伴鼻息肉、特应性皮炎等其他过敏性疾病，需要进行整体管理的患者；对通过常规治疗难以平稳度过花粉季的过敏性鼻炎患者，可以在花粉季来临前或期间进行精准施治。目前，过敏性疾病尚无法彻底根治。生物制剂可以长期、深度抑制过敏炎症，降低换季发作频率、减轻发作强度、稳定状态，以达到长期控制的目的。生物制剂并非打一次就能一劳永逸，也不是首选诊疗方式。过敏性鼻炎患者可去医院进行系统评估，让医生判断过敏类型和严重程度，并制订合适的方案。此外，针对难治性过敏性鼻炎，高选择性翼管神经切断术等外科干预方式，也可作为一种可行的替代治疗方案。

Processing status

Not selected for analysis

Screened and not selected for analysis. The original record is stored; no analysis summary was produced.

Provenance

What is known about this record and where each part came from.
Desk	China Desk
Publishing institution	CMC Political Work Department
Source outlet	PLA Daily (解放军报) (pla_daily)
Source language	zh-Hans — an attribute of the source, not of this record
Source-stated publication date	2026-10-25
Original URL	http://www.81.cn/yw_208727/16495981.html
Collected at	2026-10-25 17:03:39 — collection metadata, not a publication time
Content fingerprint	4d99aa64e809f1cade690866f0c076b1ad91fa663531c8202ecfb8f52a84f194 — taken when the record was captured, over the stored original title and text
Collection run	183
Title translation model	claude-sonnet-4-6
Title translation prompt	china-title-v1
Title translated at	2026-10-25T17:16:30.045763+00:00

Every field above is defined in the data dictionary — what it means, when it may be absent, and where it stops being reliable.

What this record supports

Source record This item was published at the URL above on the date the source stated.
Official claim Its contents are that institution's assertions.

It does not establish that the described events occurred, that any capability exists, or that the institution's stated position is its actual policy.

Cite this record

Two separate claims, cited separately: the item as its publisher issued it, and the record as this corpus holds it.

Source text. CMC Political Work Department. "过敏性鼻炎有了新疗法." PLA Daily (解放军报), 2026-10-25. http://www.81.cn/yw_208727/16495981.html.

As held. Indo-Pacific Record, Research Atlas corpus, Record 5641, Snapshot — 2026-10-25 (1,236 records).

Processing note. This record was screened and not selected for analysis. No analysis summary was produced. The English title is machine-translated; human review is not recorded.

The record number and this record path are locators inside the 2026-10-25 snapshot. Neither is a DOI, accession number, permanent identifier, public permalink, or published route. See identifiers and citation guidance.

25 October 2026 Sunday Source-stated publication date

CMC Political Work Department
via PLA Daily (解放军报)